Key Points
- CeriBell CEO Xingjuan Chao sold 39,540 shares at an average price of $24.61, generating approximately $973,000; her remaining stake declined 4.9% to 767,191 shares.
- CeriBell shares opened at $24.72, near their 52-week high of $25.33, while the company reported quarterly revenue of $28.1 million but missed earnings expectations with a loss of $0.51 per share.
- Analyst sentiment remains generally positive, with a “Moderate Buy” consensus and an average price target of $24.40, although ratings range from Strong Buy to Sell.
CeriBell, Inc. (NASDAQ:CBLL - Get Free Report) CFO Scott Blumberg sold 652 shares of the business's stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $25.00, for a total value of $16,300.00. Following the transaction, the chief financial officer directly owned 146,600 shares of the company's stock, valued at approximately $3,665,000. The trade was a 0.44% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.
Scott Blumberg also recently made the following trade(s):
- On Friday, August 21st, Scott Blumberg sold 1,521 shares of CeriBell stock. The shares were sold at an average price of $24.02, for a total transaction of $36,534.42.
- On Wednesday, August 19th, Scott Blumberg sold 33,512 shares of CeriBell stock. The stock was sold at an average price of $25.03, for a total transaction of $838,805.36.
- On Tuesday, August 18th, Scott Blumberg sold 990 shares of CeriBell stock. The shares were sold at an average price of $25.00, for a total transaction of $24,750.00.
CeriBell Stock Performance
NASDAQ CBLL opened at $24.72 on Friday. The firm's fifty day moving average price is $20.67 and its two-hundred day moving average price is $19.49. The stock has a market cap of $948.75 million, a PE ratio of -14.05 and a beta of 0.95. The company has a debt-to-equity ratio of 0.16, a quick ratio of 8.79 and a current ratio of 9.18. CeriBell, Inc. has a fifty-two week low of $10.85 and a fifty-two week high of $25.33.
CeriBell (NASDAQ:CBLL - Get Free Report) last issued its quarterly earnings data on Monday, August 10th. The company reported ($0.51) earnings per share for the quarter, missing analysts' consensus estimates of ($0.47) by ($0.04). CeriBell had a negative return on equity of 44.85% and a negative net margin of 64.73%.The firm had revenue of $28.10 million for the quarter, compared to the consensus estimate of $27.28 million. On average, equities analysts expect that CeriBell, Inc. will post -1.96 EPS for the current fiscal year.
Analyst Ratings Changes
A number of analysts recently weighed in on CBLL shares. Barclays upgraded CeriBell to a "neutral" rating in a report on Tuesday, August 18th. Weiss Ratings downgraded shares of CeriBell from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Friday, August 28th. BTIG Research upped their price objective on shares of CeriBell from $28.00 to $30.00 and gave the company a "buy" rating in a research note on Tuesday, August 18th. Canaccord Genuity Group lifted their target price on shares of CeriBell from $25.00 to $26.00 and gave the stock a "buy" rating in a research note on Tuesday, August 11th. Finally, Raymond James Financial reiterated a "strong-buy" rating and set a $29.00 price target on shares of CeriBell in a report on Thursday. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $24.40.
Read Our Latest Analysis on CBLL
Institutional Trading of CeriBell
Large investors have recently made changes to their positions in the company. California State Teachers Retirement System raised its stake in CeriBell by 409.5% during the 2nd quarter. California State Teachers Retirement System now owns 7,352 shares of the company's stock worth $143,000 after buying an additional 5,909 shares during the period. Wellington Management Group LLP increased its holdings in shares of CeriBell by 5.5% during the second quarter. Wellington Management Group LLP now owns 87,698 shares of the company's stock valued at $1,706,000 after acquiring an additional 4,572 shares in the last quarter. Formula Growth Ltd. acquired a new position in shares of CeriBell during the second quarter worth approximately $603,000. Bank of America Corp DE acquired a new stake in shares of CeriBell in the 2nd quarter worth about $4,619,000. Finally, PDT Partners LLC acquired a new position in CeriBell during the 2nd quarter valued at about $1,026,000.
About CeriBell
(
Get Free Report)
CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell's solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.
The company's product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
